Director/PDMR Shareholding

Integrated Diagnostics Holdings PLC
14 June 2023
 

INTEGRATED DIAGNOSTICS HOLDINGS PLC

 (the "Company")
Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Hena Holdings Ltd

2.

Reason for the notification

 

a)

Position / status

PCA of Dr Hend El Sherbini, Chief Executive Officer

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Integrated Diagnostics Holding plc

 

b)

LEI

2138007JN9NUWKKTS790

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

 

Identification Code

IDH Ordinary Shares of $0.25 each

 

 

JE00BLKGSR75

b)

Nature of the transaction

Purchase of shares

 

 

c)

Price(s) and volume(s)

Price(s) per share

Volume(s)

USD  0.3820

150,000

d)

Aggregated information

 

Aggregated volume

Price

150,000

 

USD0.3820 per share

 

e)

Date of the transaction

12 June 2023

 

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings